Gilead Sciences Inc. (GILD)

Last Three Months

22-Aug-24 -- 21-Nov-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Strong Sell

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

41

0

0

+1

0

+2

0

+3

Two Year Chart

22-Nov-22 -- 21-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
11-Sep-24 7:30 PM View:	10-Sep-24 Payment of Exercise ($386.76K)	O'Day Daniel Patrick Chairman & CEO Director		Gilead Sciences Inc. - GILD	1% 490.45K to 496.0K	0	0	--	--	Show Txns Hide Txns

13-Sep-24 5:08 PM View:	12-Sep-24 Private Sale (Planned) ($2.46M)	Mercier Johanna Chief Commercial Officer		Gilead Sciences Inc. - GILD	(32%) 114.98K to 78.13K	0	0	--	--	Show Txns Hide Txns

02-Oct-24 4:58 PM View:	01-Oct-24 Private Sale (Planned) ($167.66K)	Parsey Merdad Chief Medical Officer		Gilead Sciences Inc. - GILD	4% 96.38K to 100.19K	0	0	--	--	Show Txns Hide Txns

11-Sep-24 7:20 PM View:	10-Sep-24 Payment of Exercise ($136.98K)	Dickinson Andrew D Chief Financial Officer		Gilead Sciences Inc. - GILD	1% 136.96K to 138.92K	0	0	--	--	Show Txns Hide Txns

11-Sep-24 7:41 PM View:	10-Sep-24 Payment of Exercise ($25.00K)	Telman Deborah H EVP, Corporate Affairs & GC		Gilead Sciences Inc. - GILD	2% 20.38K to 20.71K	0	0	--	--	Show Txns Hide Txns

11-Sep-24 7:38 PM View:	10-Sep-24 Payment of Exercise ($23.78K)	Patterson Sandra SVP, Controllership		Gilead Sciences Inc. - GILD	2% 35.98K to 36.59K	0	0	--	--	Show Txns Hide Txns